DHC during the CoVID-19 pandemic: Most DHC services are available remotely but we’re building new alternatives when needed to ensure that we continue to help you move your program forward. For example, we now offer a Virtual Remote Audit. If that is of interest, or if you wish to request other remote services, please request a consultation.

Cell & Gene Therapy Specialists

Our team of experienced cell and gene therapy professionals bring deep domain expertise to assist our clients in achieving their strategic and operational objectives

Services

We apply pharmaceutical industry best practices to the unique challenges of the Cell and Gene Therapy (C&GT) field. Our team can help you with a wide range of needs, spanning from high level corporate strategy development to detailed technical implementation.

We have a dozen commonly-requested services, listed below. 

Watch this space biweekly for new case studies (select green buttons below). The latest: a Preclinical Comparability case study (listed below under Process Dev & Comparability as well as Preclinical Development). 

  • Quantitative modeling
  • CMO selection
  • Technology transfer
  • Facility design
  • Failure analysis

  • Comparability studies
  • Process codification
  • Process evaluation 
  • Process dev planning


  • Method development
  • Specification setting
  • Method transfer
  • Qualification & validation
  • Remediation
  • Comparability testing
  • Capacity planning
  • Cost-of-goods analysis
  • Build vs. Buy analytics
  • QMS design and strategy
  • QMS gap assessment
  • Document authoring, review, and revision
  • Supplier oversight
  • Audits (see flyer below)
  • URS development
  • Landscape scan & gap analysis
  • Custom device design
  • Contract manufacturing management
  • DHF & DMF development
  • Regulatory strategy
  • Technical writing/editing
  • Gap analyses
  • Meeting assistance
  • Preclinical strategy
  • Study design and oversight
  • Vendor selection
  • Technical writing
  • Critical path identification
  • Project management
  • Strategic project planning
  • Stage-gating
  • Needs assessment
  • Voice-of-customer surveys
  • Marketing strategy



  • Strategic portfolio
    assessment & analysis
  • Landscape analysis and competitive intelligence
  • IP due diligence
  • IP strategy
  • Due diligence
  • Message optimization
  • Bespoke introductions



Jerrod Denham, DHC Principal and eminent risk-taker, takes today's #DHCinperson spotlight. He was one of the first to ever culture human embryonic stem cells, was DHC's first employee, and never let the infamous "Denham travel curse" get him down. https://bit.ly/Jerrodinperson

The latest addition to our #DHCcasestudy page (https://bit.ly/DHCcasestudies) takes a look at the design & outsourcing of preclinical studies to demonstrate product comparability...aka, a snapshot of the overlap b/t #DHCservices in Preclinical Dev and Process Dev/Comparability. Enjoy!

In this week's #DHCinperson, meet Principal Katie Miller. By age seven she knew she wanted to be a scientist and, now? Well, now she has a quarter of a century's worth of experience in C&GT **and** an IMDb page. Not too shabby! https://bit.ly/Katieinperson

Our latest #DHCcasestudy (click on the first option on our new https://bit.ly/DHCcasestudies page) demonstrates how #DHCservices IP+diligence+market research in C&GT must also take into consideration the extraordinary complexities of the space, something we are uniquely equipped to do.

We use cookies to help give you the best experience on our website. By continuing you agree to our use of cookies.